Your browser doesn't support javascript.
loading
The potential of turmeric extract-loaded chitosan microparticles for the treatment of gastrointestinal disorders.
Mittraparp-Arthorn, Pimonsri; Ungphaiboon, Suwipa; Takahashi Yupanqui, Chutha; Suwannasin, Sirikan; Wijukkul, Chutikan; Tanmanee, Niwan; Srichana, Teerapol.
  • Mittraparp-Arthorn P; Division of Biological Sciences, Faculty of Sciences, Prince of Songkla University, Songkhla, Thailand.
  • Ungphaiboon S; Drug Delivery System Excellence Center, Department of Pharmaceutical Technology, Faculty of Pharmaceutical Sciences, Prince of Songkla University, Songkhla, Thailand.
  • Takahashi Yupanqui C; Center of Excellence in Functional Foods and Gastronomy, Faculty of Agro-Industry, Prince of Songkla University, Songkhla, Thailand.
  • Suwannasin S; Division of Biological Sciences, Faculty of Sciences, Prince of Songkla University, Songkhla, Thailand.
  • Wijukkul C; Division of Biological Sciences, Faculty of Sciences, Prince of Songkla University, Songkhla, Thailand.
  • Tanmanee N; Pharmaceutical Laboratory Service Center, Faculty of Pharmaceutical Sciences, Prince of Songkla University, Songkhla, Thailand.
  • Srichana T; Drug Delivery System Excellence Center, Department of Pharmaceutical Technology, Faculty of Pharmaceutical Sciences, Prince of Songkla University, Songkhla, Thailand.
J Microencapsul ; : 1-17, 2024 Aug 14.
Article en En | MEDLINE | ID: mdl-39140474
ABSTRACT

AIM:

To develop turmeric extract-loaded chitosan microparticles for treating gastrointestinal disorders.

METHODS:

The microparticles were prepared using a spray-drying process, optimised the characteristics by biomarker loading, and encapsulation efficiency, and assessed for bioactivities related to gastrointestinal diseases.

RESULTS:

The optimised microparticles were spherical, with a mean diameter of 2.11 ± 0.34 µm, a SPAN of 4.46 ± 0.68, a zeta potential of +37.6 ± 0.2 mV, loading of 15.7% w/w curcuminoids, 5.4% w/w ar-turmerone, and encapsulation efficiency of 63.26 ± 1.62% w/w curcuminoids and 43.75 ± 1.33% w/w ar-turmerone. Encapsulation of turmeric extract improved release at 6 h by 20 times and mucoadhesion by 3.6 times. The microparticles exhibited high acid-neutralising capacity (1.64 ± 0.34 mEq/g) and inhibited nitric oxide production about twice as effectively as the turmeric extract, while maintaining antioxidant and antibacterial activities.

CONCLUSION:

Encapsulation of turmeric extract in chitosan microparticles effectively enhanced therapeutic potential for gastrointestinal disorders.
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2024 Tipo del documento: Article